维普期刊资源整合服务平台（V6.5）

100篇 您的检索式：作者名="Tan DS"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	PPM1D is a potential therapeutic target in ovarian clear cell carcinomas 显示文摘	Tan DS Lambros MB Rayter S	2009	Clin Cancer Res2009，15，7：	1
2	Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracy- dine-treated patients 显示文摘	Tan DS Marehio C Jones RL	2008	Breast Cancer Res Treat2008，111，5：	1
3	Ovarian cancer: can we reverse drug resistance? 显示文摘	Tan DS Ang JE Kaye SB	2008	Adv Exp Med Biol2008，622，：	1
4	Triple negative breast cancer:molecular profiling and prognostic impact in adjuvant anthracycline treated patients显示文摘	Tan DS MarchióC Jones RL	2008	Breast Cancer Res Treat2008，111，1：	1
5	New perspectives on molecular tar- geted therapy in ovarian clear cell carcinoma 显示文摘	Tan DS Miller RE Kaye SB	2013	Br J Cancer2013，108，8：	1
6	Comparative genomic hybridisation arrays:high-through put tools to determine targeted therapy in breast cancer 显示文摘	Tan DS Reis-Filho JS	2008	Pathobiology2008，75，2：	1
7	Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy 显示文摘	Koo YX Tan DS Tan IB	2010	Cancer2010，116，11：	1
8	PPM1D is a potential ther- apeutic target in ovarian clear cell carcinomas 显示文摘	Tan DS Lambros MB Raper S	2009	Clin Cancer Res2009，15，7：	1
9	Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline - treated patients显示文摘	Tan DS Marchio C Jones RL	2007	Breast Cancer Res Treat2007，6，：	1
10	Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline treated patient 显示文摘	Tan DS Marchio C Jones RL	2008	Breast Cancer Res Treat2008，111，1：	1
11	Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth显示文摘	Boyd SR Tan DS Souza LD	2002	Br J Ophthalmol2002，86，4：	1
12	H-caldesmon,a novel smooth muscle-specific antibody,distinguishes between cellular leiomyoma and endometrial stromal sarcoma 显示文摘	Rush DS Tan J Baergen RN	2001	Am J Surg Pathol2001，25，2：	1
13	Truth about ERCC1 in lung cancer 显示文摘	Tan DS Ng QS Tan IB	2010	JClinOncol2010，28，10：	1
14	Meeting the challenge of ascites in ovarian cancer:new avenues for therapy and research显示文摘	Kipps E Tan DS Kaye SB	2013	Nat Rev Cancer2013，13，4：	1
15	Doctor-patient communication, health-related beliefs, and ad-herence in glaucoma results from the Glaucoma Adherence andPersistency Study显示文摘	Friedman DS Hahn SR (Gelb L Tan J Shah SN Kim EE	2008	Ophthalmology2008，115，8：	1
16	Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients显示文摘	Tan DS Marchio C Jones RL	2008	Breast Cancer Res Treat2008，111，1：	1
17	Triple negative breast cancer:molecular profiling and prognostic impact in adjuvant anthracycline-treated patients显示文摘	Tan DS Marchi6 C Jones RL	2008	Breast Cancer Res Treat2008，111，1：	1
18	Fluoride treatment and in vitro corrosion behavior of an AZSIB magnesium alloy 显示文摘	Yan TT Tan LL Xiong DS	2010	Mater Sci Engineer C2010，30，5：	1
19	One-year nmhicenter, double- masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia 显示文摘	Tan DT Lain DS Chua WH	2005	Ophthalmology2005，112，1：	1
20	Ovarian cancer:can we reverse drug resistance显示文摘	Tan DS Ang JE Kaye SB		0，，08：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示